|
Commitments and Contingencies (Details) (Abbott Biotherapeutics Corp [Member], USD $)
|
3 Months Ended |
|---|---|
|
Mar. 31, 2014
|
|
|
Phase I Clinical Trial of a licensed product [Member]
|
|
| Summary of milestone payment | |
| Milestones payments | $ 750,000 |
|
Phase II Clinical Trial of a licensed product [Member]
|
|
| Summary of milestone payment | |
| Milestones payments | 750,000 |
|
Phase III Clinical Trial of a licensed product [Member]
|
|
| Summary of milestone payment | |
| Milestones payments | 1,500,000 |
|
Biological License Application filing with U.S. FDA [Member]
|
|
| Summary of milestone payment | |
| Milestones payments | 1,750,000 |
|
First Commercial Sale [Member]
|
|
| Summary of milestone payment | |
| Milestones payments | 1,500,000 |
|
After First Net Sales [Member]
|
|
| Summary of milestone payment | |
| Milestones payments | $ 1,500,000 |